# Disrupt PAD BTK II Study With the Shockwave Peripheral IVL System

> **NCT05007925** · NA · COMPLETED · sponsor: **Shockwave Medical, Inc.** · enrollment: 250 (actual)

## Conditions studied

- Peripheral Artery Disease

## Interventions

- **DEVICE:** Intravascular Lithotripsy

## Key facts

- **NCT ID:** NCT05007925
- **Lead sponsor:** Shockwave Medical, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-18
- **Primary completion:** 2024-03-25
- **Final completion:** 2026-03-27
- **Target enrollment:** 250 (ACTUAL)
- **Last updated:** 2026-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05007925

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05007925, "Disrupt PAD BTK II Study With the Shockwave Peripheral IVL System". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05007925. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*